Deprescribing in Psychiatry - Swapnil Gupta, John Cahill, Rebecca Miller

Deprescribing in Psychiatry

Buch | Softcover
264 Seiten
2019
Oxford University Press Inc (Verlag)
978-0-19-065481-8 (ISBN)
64,80 inkl. MwSt
The current state of medicine has witnessed the long-term adverse effects of certain medications, an increased rate of polypharmacy, and a cultural shift that emphasizes patient-centered practice. The term "deprescribing" refers to the optimization of the pharmacological regimen by reducing or cessing medications that incur more risks than benefits.

Many people consider stopping their psychiatric medications, but prescribers may not know how to do this in a collaborative, systematic way. Deprescribing in Psychiatry presents a framework for deprescribing to guide the prescriber-patient dyad through the process of deciding if and when to reduce psychiatric medication, how to go about doing it, and at the same time, acknowledge the inherent risks in such an endeavour.

As the first book on the subject, Deprescribing in Psychiatry stands to serve as a definitive text in this burgeoning field and as a 'rallying call' to raise crucial and topical questions in psychiatric practice, promote innovation, and act as a resource on the current state-of-the-art care. It describes the ins and outs of how clinicians can work closely with their patients to consider whether or not to try decreasing medications. It also discusses the anticipated future research directions, considerations for the field, and emphasizes collaboration with the patient, transparency, and the acknowledgement of uncertainty in psychiatric practice.

Swapnil Gupta, MBBS, MD Assistant Professor, Department of Psychiatry, Yale University School of Medicine;John D. Cahill, BMBS, PhD, , Assistant Professor, Department of Psychiatry, Yale University School of Medicine; Rebecca Miller, PhD, Assistant Professor, Department of Psychiatry, Yale University School of Medicine

Preface
Chapter 1 Introduction
Chapter 2 Decision making in deprescribing
Chapter 3 Barriers to deprescribing
Chapter 4 Non pharmacological considerations
Chapter 5 Wellness approaches I: Self-determined strategies
Chapter 6 Wellness approaches II: Collaborative strategies
Chapter 7 Process of deprescribing
Chapter 8 Deprescribing antidepressant medications
Chapter 9 Deprescribing antipsychotic medications
Chapter 10 Deprescribing mood stabilizers medications
Chapter 11 Deprescribing benzodiazepine and stimulants
Chapter 12 Conclusions and future directions
Afterword

Erscheinungsdatum
Verlagsort New York
Sprache englisch
Maße 155 x 231 mm
Gewicht 386 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Medizinethik
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Medizin / Pharmazie Medizinische Fachgebiete Psychiatrie / Psychotherapie
ISBN-10 0-19-065481-3 / 0190654813
ISBN-13 978-0-19-065481-8 / 9780190654818
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich